Department of Biotechnology under the Union Government has granted its certification to the Biosafety Level – 3 Laboratory of ...
Manipal Academy of Higher Education (MAHE), an Institution of Eminence Deemed to be University, proudly announces the successful certification of its Biosafety Level-3 (BSL-3) Laboratory by Department ...
The lowest of the four biosafety levels and is suitable for work involving well-characterized agents not known to consistently cause disease in healthy adult humans. These organisms pose minimal ...
BSL-2 is designed for work with agents that pose moderate hazards to personnel and the environment. These agents are associated with human diseases that are generally treatable or preventable. Agents ...
In Manhattan, Kan., the National Bio and Agro-Defense Facility (NBAF), an animal disease research facility, has finished construction. Replacing the 68-year-old Plum Island Animal Disease Center, NBAF ...
On May 25, 2023, merely six weeks before the Wuhan Biosafety lab lost its NIH funding amid the controversy of possible lab leaks and connection with COVID-19, the U.S. proudly opened the doors of the ...
ENFIELD, Conn.--(BUSINESS WIRE)--Eppendorf is proud to announce they have received Connecticut State approval to conduct Biosafety Level 2 (BL2) infectious disease related research. This greatly ...
Vanderbilt University Medical Center has been awarded a nearly $8 million grant to construct a facility for research involving COVID-19, anthrax, tuberculosis and other dangerous microorganisms. The ...
If NIH prioritizes human-based science in its ongoing overhaul of biosafety policies, the oversight system that has evolved for review of a wide-swath of biological research could atrophy and expose ...
A former senior adviser to National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci shared “confidential” communications with EcoHealth Alliance about how the agency was ...
The NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acids (NIH Guidelines) provide details regarding "the practices for constructing and handling: (i) recombinant nucleic acid ...